e-learning
resources
Berlin 2001
Sunday 23.09.2001
Exercise (miscellanea)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Has cardiopulmonary exercise testing a role in detecting early emphysema in alpha 1-antitrypsin deficiency?
E. Boni, D. Franchini, L. Corda, L. Pini, L. Carminati, V. Grassi, C. Tantucci (Brescia, Italy)
Source:
Annual Congress 2001 - Exercise (miscellanea)
Session:
Exercise (miscellanea)
Session type:
Thematic Poster Session
Number:
620
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Boni, D. Franchini, L. Corda, L. Pini, L. Carminati, V. Grassi, C. Tantucci (Brescia, Italy). Has cardiopulmonary exercise testing a role in detecting early emphysema in alpha 1-antitrypsin deficiency?. Eur Respir J 2001; 16: Suppl. 31, 620
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Smoke exposure as a determinant of autoantibody titre in alpha 1-antitrypsin deficiency and COPD
Source: Eur Respir J 2011; 37: 32-38
Year: 2011
Any role for cardiopulmonary exercise test as an outcome in severe asthmatic patients after the initiation of biological therapy?
Source: Virtual Congress 2020 – From respiratory physiology to clinical practice: exercise and respiratory muscles
Year: 2020
The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2018 – PG16 Advanced cardiopulmonary exercise testing
Year: 2018
The prognostic role of cardiopulmonary exercise testing in disease
Source: International Congress 2019 – PG3 Advanced cardiopulmonary exercise testing
Year: 2019
The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease
Source: Eur Respir J, 57 (6) 2100115; 10.1183/13993003.00115-2021
Year: 2021
The evolving role of exercise testing in the pulmonary patient
Source: Annual Congress 2009 - PG17 Cardiopulmonary exercise testing in the evaluation of the respiratory patient
Year: 2009
Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency
Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content
Year: 2018
Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019
Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres
Source: Eur Respir J 2010; 35: 960-968
Year: 2010
Targeted screening programmes in COPD: how to identify individuals with alpha 1-antitrypsin deficiency
Source: Eur Respir Rev 2015; 24: 40-45
Year: 2015
The role of cardiopulmonary exercise testing in the investigation of complex unexplained breathlessness
Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases
Year: 2017
Specific airway resistance as a marker of early disease in alpha-1 antitrypsin deficiency
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation
Source: Eur Respir J, 50 (3) 1700962; 10.1183/13993003.00962-2017
Year: 2017
Any role for cardiopulmonary exercise test in symptomatic smokers with borderline spirometry?
Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases
Year: 2018
Diagnosing alpha 1-antitrypsin deficiency: how to improve the current algorithm
Source: Eur Respir Rev 2015; 24: 52-57
Year: 2015
The role of cardiopulmonary exercise testing in assessment of the severity of patients with PAH associated with congenital heart disease.
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019
Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002
Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients
Source: Eur Respir J, 57 (1) 2004265; 10.1183/13993003.04265-2020
Year: 2021
Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
COVID-19 infection in Severe Alpha 1-antitrypsin deficiency: looking for a rationale
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept